CY2-30256-58315
4 vaccinations
5 coded responses
39 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 482 / MI
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-08
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity, Rhinorrhoea — Feeling: GoodFree text: A little bit of a runny nose is most likely spring allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Arm is sore at injection site, not pain just soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — day 7, dose 1MedDRA: Injection site discomfort, Injection site pain, Pain — Feeling: GoodFree text: Soreness, not quite pain, to the touch at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
-
2021-09-24
Survey response — 6 months, dose 2MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-09-29
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-21
Dose 3 — Pfizer-BioNTech
- 2021-10-25
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Location of injection is still bruisedMedDRA releases: 2024-11 · check-in free text available
- 2021-10-27
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2022-01-20
- 2022-04-21
-
2022-09-10
Dose 4 — Moderna
- 2022-10-24
- 2022-10-24
- 2022-12-10
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-10 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): A little bit of a runny nose is most likely spring allergies
Systemic reaction (other): Arm is sore at injection site, not pain just sore
Release 5 — day 7, dose 1
Systemic reaction (other): Soreness, not quite pain, to the touch at injection site
Release 9 — 6 months, dose 2
Symptoms: Sinus infection
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Location of injection is still bruised
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain | ○ | ✓ | ○ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release